Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gigcapital2 Inc (GIX)

Gigcapital2 Inc (GIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 185,837
  • Shares Outstanding, K 19,812
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,200 K
  • 60-Month Beta 0.08
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 37.17
Trade GIX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.65 +8.44%
on 06/01/21
10.72 -12.50%
on 06/08/21
-0.66 (-6.57%)
since 05/07/21
3-Month
8.65 +8.44%
on 06/01/21
10.72 -12.50%
on 06/08/21
-0.67 (-6.67%)
since 03/09/21
52-Week
8.65 +8.44%
on 06/01/21
12.12 -22.61%
on 12/07/20
-0.67 (-6.67%)
since 06/09/20

Most Recent Stories

More News
Medigus: Gix Internet Reports Over $45 Million in Revenues for 2021

Medigus expects to consolidate Gix Internet’s financial results during 2022 Tel Aviv, Israel, March 31, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq:...

MDGS : 2.36 (+8.28%)
GIX : 9.38 (-10.41%)
Medigus: Jeff Brands to Enter the Logistic Warehouses Market in the U.S. to Support Amazon FBM Sellers E-commerce Growth

Jeff Brands will develop dedicated software for managing inventory and logistics warehouses to support e- commerce businesses

MDGS : 2.36 (+8.28%)
SCTC : 2.7000 (-10.00%)
GIX : 9.38 (-10.41%)
Medigus Ltd. Announces Record High Financial Results

Revenues for the first half of 2021 increased by ~3,178% with first ever net profit of approximately $8 million

MDGS : 2.36 (+8.28%)
SCTC : 2.7000 (-10.00%)
GIX : 9.38 (-10.41%)
Medigus: Revoltz Commenced Prototype Manufacturing of its Micro-mobility Vehicle

Revoltz Model One is a micro-mobility vehicle for last mile and food delivery.

MDGS : 2.36 (+8.28%)
SCTC : 2.7000 (-10.00%)
GIX : 9.38 (-10.41%)
Medigus: Polyrizon to Test its Product Candidate for Protection Against High Transmissible Corona Virus Delta Variant B.1.617.2

In recent pre- clinical studies, Polyrizon products showed strong potential in preventing human coronavirus 229E and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells'...

MDGS : 2.36 (+8.28%)
SCTC : 2.7000 (-10.00%)
GIX : 9.38 (-10.41%)
Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue

In recent pre- clinical studies, Polyrizon products showed strong potential by preventing coronavirus and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells' death....

SCTCD : 9.5000 (-7.77%)
MDGS : 2.36 (+8.28%)
SCTC : 2.7000 (-10.00%)
GIX : 9.38 (-10.41%)
Medigus: Gix Media to Acquire 70% of Leading Innovative Media-Tech Company Cortex Group for Approximately $11 Million

Gix Internet finished the first six months of 2021 with revenues of ~$ 16.4 million, Cortex Group Revenues for the first six months of 2021 amounted to ~$ 12.3 million

MDGS : 2.36 (+8.28%)
GIX : 9.38 (-10.41%)
Medigus: Increases Holdings in Gix to Approximately 36.7% on a Fully Diluted Basis

OMER, Israel, July 07, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that it exercised...

MDGS : 2.36 (+8.28%)
GIX : 9.38 (-10.41%)
Medigus Ltd. Issues CEO Letter to its Shareholders

OMER, Israel, June 14, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today released a letter...

MDGS : 2.36 (+8.28%)
SCTC : 2.7000 (-10.00%)
GIX : 9.38 (-10.41%)
UpHealth and GigCapital2 Announce Closing of Business Combinations

GigCapital2, Inc. (“GigCapital2”) (NYSE: GIX, GIX.U, GIX.RT, and GIX.WS) today announced the completion of its previously announced business combinations with UpHealth Holdings, Inc. (“UpHealth...

GIX : 9.38 (-10.41%)
GIWWU : 10.26 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GigCapital2 Inc. is a blank check company. It formed for the purpose of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. GigCapital2 Inc. is based in Palo Alto, United States.

See More

Key Turning Points

3rd Resistance Point 11.25
2nd Resistance Point 10.87
1st Resistance Point 10.13
Last Price 9.38
1st Support Level 9.01
2nd Support Level 8.63
3rd Support Level 7.89

See More

52-Week High 12.12
Fibonacci 61.8% 10.79
Fibonacci 50% 10.39
Fibonacci 38.2% 9.98
Last Price 9.38
52-Week Low 8.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar